CIK 0001880438
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 820606654
- Phone
- +1 650-331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $11,602
- in 1 filing
- Open-market sales, last 90 days
- $117,428
- in 4 filings, $104K under 10b5-1 plans
Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-07 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −2,841 | $16.05 | $46K | 2,177,883 |
| 2023-09-07 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −537 | $16.05 | $9K | 411,957 |
| 2023-09-07 | Aziz Kabeer Director | Sale | −2,841 | $16.05 | $46K | 2,177,883 |
| 2023-09-07 | Aziz Kabeer Director | Sale | −537 | $16.05 | $9K | 411,957 |
| 2023-09-06 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −3,164 | $16.02 | $51K | 2,180,724 |
| 2023-09-06 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −598 | $16.02 | $10K | 412,494 |
| 2023-09-06 | Aziz Kabeer Director | Sale | −3,164 | $16.02 | $51K | 2,180,724 |
| 2023-09-06 | Aziz Kabeer Director | Sale | −598 | $16.02 | $10K | 412,494 |
| 2023-08-23 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −336 | $16.00 | $5K | 2,183,888 |
| 2023-08-23 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −64 | $16.00 | $1K | 413,092 |
| 2023-08-23 | Aziz Kabeer Director | Sale | −336 | $16.00 | $5K | 2,183,888 |
| 2023-08-23 | Aziz Kabeer Director | Sale | −64 | $16.00 | $1K | 413,092 |
| 2023-08-18 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +1,777,778 | $9.00 | $16.0M | 5,135,683 |
| 2023-06-07 | Aziz Kabeer Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | Zakrzewski Joseph S Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | FitzPatrick Margaret M Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | Wong Stephanie Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | Marks Gilbert Lynn Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | Martin Patricia A. Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-06-07 | Spigelman Melvin K Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 |
Page 14 of 20 · 385 trades